{"id":"7302bd0d-6b39-5335-b91f-d8a027926b71","stable_key":"52871722-4aa6-5453-a902-3e76356db327:resveratrol-epac-loss","predicate":"silencing_blocks","statement":"Epac1 siRNA, unlike PKA catalytic-subunit siRNA, blocked resveratrol-induced AMPK/ACC phosphorylation in human HeLa cells.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"4334dde1-f928-507a-961f-e37d8216b61c","mechanism_event_label":"A cAMP effector is a tested dependency.","subject":{"id":"eb3c3d8f-61e0-5daf-82ea-7906d7ae4f00","slug":"rapgef3","display_name":"Human Epac1 / RAPGEF3","entity_type_key":"protein"},"object":{"id":"09f934dc-e0fc-5ffc-bdfc-f5b28cc37a84","slug":"human-hela-resveratrol-ampk-response","display_name":"Resveratrol-associated AMPK activation in HeLa cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"4334dde1-f928-507a-961f-e37d8216b61c","stable_key":"52871722-4aa6-5453-a902-3e76356db327:resveratrol-epac-loss-event","event_type":"observed_relationship","label":"A cAMP effector is a tested dependency.","description":"Epac1 siRNA, unlike PKA catalytic-subunit siRNA, blocked resveratrol-induced AMPK/ACC phosphorylation in human HeLa cells.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"eb3c3d8f-61e0-5daf-82ea-7906d7ae4f00","slug":"rapgef3","display_name":"Human Epac1 / RAPGEF3","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"09f934dc-e0fc-5ffc-bdfc-f5b28cc37a84","slug":"human-hela-resveratrol-ampk-response","display_name":"Resveratrol-associated AMPK activation in HeLa cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"53549e32-e6b4-5f09-94e6-62867b015713","slug":"resveratrol","display_name":"Resveratrol","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"95bc303f-ad04-59ea-8e1e-32f9e8b72c56","slug":"human-ampk-complexes","display_name":"Human AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"HeLa experiments selected to avoid myogenesis confounding; 50 micromolar resveratrol.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"RNAi does not make all tissue responses Epac1-dependent.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"resveratrol","display_name":"Resveratrol","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"A cAMP effector is a tested dependency.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22304913/ · DOI 10.1016/j.cell.2012.01.017","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"f7d34307-35df-5a5e-9f22-d0530b26d478","evidence_kind":"source_excerpt","locator":"Lines 238-244","start_line":238,"end_line":244,"excerpt":"## resveratrol-epac-loss\nA cAMP effector is a tested dependency.\nEpac1 siRNA, unlike PKA catalytic-subunit siRNA, blocked resveratrol-induced AMPK/ACC phosphorylation in human HeLa cells.\nModel: HeLa experiments selected to avoid myogenesis confounding; 50 micromolar resveratrol.\nLimitations: RNAi does not make all tissue responses Epac1-dependent.\nEvidence access: Primary full text\nResveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22304913/ · DOI 10.1016/j.cell.2012.01.017","model_system":"HeLa experiments selected to avoid myogenesis confounding; 50 micromolar resveratrol.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"2844eda9-a122-5357-ae47-cd58227c5994","stable_key":"import-52871722-4aa6-5453-a902-3e76356db327","title":"Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"04885b4bee72f912a7f3f618f1b2bf79c944dbcb20500398c2729fc8228dcd9a","revision_id":"99504ff2-f1d3-5f4c-bc31-e1030d27a918","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}